EP3049441
ANTI-PDL1 ANTIBODY FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.9.2014EP published:
27.11.2019EP application number:
14784169.6
EPO information:
European Patent Register
Max expiry date:
25.9.2034
Title:
ANTI-PDL1 ANTIBODY FORMULATIONS
Timeline
Today
26.9.2014EP application
27.11.2019EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070, Basel, CH
Inventor
Name:
YANG, YingAddress:
South San Francisco, CA, US
Name:
ALAVATTAM, SreedharaAddress:
South Francisco, CA, US
Priority
Number:
201361883953 PDate:
27.9.2013Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61K 39/00